Immunosuppressive Therapy with Cyclosporine May Result in Acute Rejection in Post Liver Transplant Patients Treated with Ledipasvir/Sofosbuvir for Hepatitis C

被引：0
|
作者：
Zachariah, Robin [1 ]
Venkat, Deepak [1 ]
机构：
[1] Univ Hosp Case Med Ctr, Cleveland, OH USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2016年 / 111卷
关键词：
D O I：
10.14309/00000434-201610001-01795
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1795
引用
收藏
页码：S859 / S859
页数：1
相关论文
共 50 条
  • [41] Ledipasvir plus Sofosbuvir for Liver Transplant Recipients With Recurrent Hepatitis C: A Systematic Review and Meta-analysis
    Liao, H. -T.
    Tan, P.
    Huang, J. -W.
    Yuan, K. -F.
    TRANSPLANTATION PROCEEDINGS, 2017, 49 (08) : 1855 - 1863
  • [42] Acute Kidney Injury in Patients Undergoing Chronic Hepatitis C Virus Treatment With Ledipasvir/Sofosbuvir
    Brown, Patrick R.
    Sadiq, Omar
    Weick, Alexander
    Lenhart, Adrienne
    Elbatta, Mohammad
    Fernandez, Christopher
    Kutait, Anas
    Pompa, Robert
    Jafri, Syed-Mohammed
    HEPATOLOGY COMMUNICATIONS, 2018, 2 (10) : 1172 - 1178
  • [43] Resistance-associated substitution and ledipasvir/sofosbuvir therapy in Mongolian chronic hepatitis C patients
    Hsu, Shih-Jer
    Enkhzaya, Sukhee
    Lin, You-Yu
    Tseng, Tai-Chung
    Khosbayar, Tulgaa
    Tsai, Cheng-Hsueh
    Wang, Tzu-San
    Enkhtuya, Damba
    Ivshinkhorol, Dogsom
    Naranzul, Nyamsuren
    Jargalsaikhan, Badarch
    Amarsanaa, Jazag
    Baatarkhuu, Oidov
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (03) : 712 - 719
  • [44] Successful treatment of post liver transplant patients with genotype 1 hepatitis C virus with sofosbuvir and simeprevir
    Punzalan, Carmi S.
    Barry, Curtis
    Zacharias, Isabel
    Rodrigues, Julie
    Mehta, Savant
    Bozorgzadeh, Adel
    Barnard, Graham
    HEPATOLOGY, 2014, 60 : 688A - 688A
  • [45] Safety and Efficacy of Ledipasvir/Sofosbuvir (LS) with or without Ribavirin (RBV) for Treatment of Recurrent Hepatitis C Infection Post-Liver Transplant.
    Gutierrez, K.
    Scheuermann, J.
    Goldvarg, I.
    Joshi, S.
    Tyson, G.
    Bzowej, N.
    Girgrah, N.
    Anders, S.
    Loss, G.
    Therapondos, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 793 - 794
  • [46] LARGE SINGLE CENTER EXPERIENCE OF SOFOSBUVIR AND LEDIPASVIR THERAPY FOR THE TREATMENT OF PATIENTS WITH HEPATITIS C VIRUS
    Wedd, J.
    Ford, R.
    Norvell, J.
    Parekh, S.
    Cheng, N.
    Young, N.
    Patel, A.
    Maheshwari, R.
    Vora, R.
    Mgbemena, O.
    Spivey, J.
    Pillai, A.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S780 - S780
  • [47] Post-Liver Transplant Hepatitis C Therapy
    Robert S. Rahimi
    Jacqueline G. O’Leary
    Current Treatment Options in Gastroenterology, 2015, 13 (2) : 249 - 258
  • [48] Effectiveness and safety of sofosbuvir/ledipasvir +/- ribavirin treatment in liver and/or renal transplant patients with chronic hepatitis C: A single-center experience
    Akin, Mete
    Buldukoglu, Osman Cagin
    Adanir, Haydar
    Suleymanlar, Inci
    Dincer, Dinc
    Yildirim, Bulent
    SAGE OPEN MEDICINE, 2018, 6
  • [49] Recurrent membranous nephropathy and acute cellular rejection in a patient treated with direct anti-HCV therapy (ledipasvir/sofosbuvir)
    Murakami, Naoka
    Ding, Yanli
    Cohen, David J.
    Chandraker, Anil K.
    Rennke, Helmut G.
    TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (05)
  • [50] Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir
    Wang, Xiao-Xiao
    Luo, Bi-Fen
    Jiang, Han-Ji
    Cong, Xu
    Jin, Qian
    Ma, Dan-Li
    Wei, Lai
    Feng, Bo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (40) : 4554 - 4564
12345